๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of intravenous immune globulin in the therapy of children with rheumatological diseases

โœ Scribed by Chaim M. Roifman

Publisher
Springer
Year
1995
Tongue
English
Weight
740 KB
Volume
15
Category
Article
ISSN
0271-9142

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The cost of treating immune thrombocytop
The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin
โœ Sandler, S. Gerald; Novak, Sharon C.; Roland, Barbara ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 18 KB ๐Ÿ‘ 2 views

Multiple factors, including efficacy, toxicity and cost, may influence the decision to treat immune thrombocytopenic purpura (ITP) with intravenous immune globulin (IVIG) or intravenous Rho (D) immune globulin (IV RhIG). We conducted a survey of 50 hospitals in 31 states to determine the costs for t

Clinical uses of intravenous immune glob
Clinical uses of intravenous immune globulin: Immunoglobulin replacement therapy and treatment of autoimmune cytopenias
โœ Ricardo U. Sorensen; Melissa O. Kallick ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 774 KB

Intravenous immune globulin (IVIG) is indicated for IgG replacement in antibody deficiency syndromes and as immunoregulatory therapy in some autoimmune diseases. Two case histories illustrate both aspects of IVIG therapy. 1. Patient 1 is a 24-year-old male with agammaglobulinemia. He was successive